Current Investments
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | ALL
FoldRx Pharmaceuticals, Inc.
Richard Labaudiniere, Cambridge, MA, US
FoldRx develops small molecule therapeutics to treat diseases of protein misfolding and aggregation. Its pipeline is initially for hereditary amyloidosis and neurodegenerative diseases.
Forma Therapeutics Inc.
Steven Tregay, Cambridge, MA, US
http://www.formatherapeutics.com
Forma Therapeutics technologies enable screening, identification and characterization of small molecules that exhibit different binding modes. The technology applies peptides, protein or small molecules as ligands to probe/assay interaction sites and the implementation of high throughput screening assays for identification of novel small molecules for specific target sites in oncology and ID.